FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT)

被引：0
|
作者：
De Martin, E. [1 ]
Senzolo, M. [1 ]
Ponziani, F. R. [2 ]
Pasulo, L. [12 ]
Gasbarrini, A. [2 ]
Vigano, R. [3 ]
Belli, L. [3 ]
Donato, F. [4 ]
Angelico, M. [5 ]
Di Paolo, D. [5 ]
Rendina, M. [6 ]
Miglioresi, L. [7 ]
Grazi, G. [8 ]
Morelli, M. C. [8 ]
Toniutto, P. [9 ]
Merli, M. [10 ]
Jemmolo, M. [11 ]
Gerunda, G. E. [11 ]
Fagiuoli, S. [12 ]
Burra, P. [1 ]
机构：
[1] Univ Padua Polyclin, Padua, Italy
[2] Policlin Gemelli, Rome, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
[4] Policlin Univ, Milan, Italy
[5] Policlin Torvergata, Rome, Italy
[6] Ospedale Univ, Bari, Italy
[7] S Camillo Forlanini, Rome, Italy
[8] Policlin Univ, Bologna, Italy
[9] Osped Univ, Udine, Italy
[10] Policlin Umberto 1, Rome, Italy
[11] Policlin Univ, Modena, Italy
[12] Osped Riuniti Bergamo, Bergamo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷
关键词：
D O I：
10.1016/S1590-8658(10)60454-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.N.49
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [31] EFFECT OF ANTIVIRAL TREATMENT, RETREATMENT, AND STAGE OF FIBROSIS ON PROGRESSION OF LIVER FIBROSIS, AND OUTCOME AFTER LIVER TRANSPLANTATION.
    Roche, Bruno
    Sebagh, Mylene
    Acanfora, Anna Maria
    Antonini, Teresa
    Afonso, Anne-Marie Roque
    Delvart, Valerie
    Castaing, Denis
    Samuel, Didier
    LIVER TRANSPLANTATION, 2008, 14 (07) : S236 - S236
  • [32] Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?
    De Martin, Eleonora
    Rodriguez-Castro, Kryssia I.
    Vitale, Alessandro
    Zanus, Giacomo
    Senzolo, Marco
    Russo, Francesco Paolo
    Burra, Patrizia
    FUTURE VIROLOGY, 2011, 6 (10) : 1179 - 1186
  • [33] Treatment of acute cellular rejection episodes does not influence fibrosis progression rate in patients with recurrence HCV after liver transplantation
    Manousou, Pinelopi
    Tsochatzis, Emmanuel
    Parisi, Ioanna
    Saffioti, Francesca
    Mansell, Alexandra
    Aspite, Silvia
    Patch, David W.
    O'Beirne, James
    Thorburn, Douglas
    Tu Vinh Luong
    Dhillon, Amar P.
    Pinzani, Massimo
    Burroughs, Andrew K.
    HEPATOLOGY, 2014, 60 : 452A - 452A
  • [34] Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation
    Trak-Smayra, V
    Contreras, J
    Dondero, F
    Durand, F
    Dubois, S
    Sommacale, D
    Marcellin, P
    Belghiti, J
    Degott, C
    Paradis, V
    TRANSPLANTATION, 2004, 77 (11) : 1755 - 1760
  • [35] Impact of antiviral therapy on fibrosis progression due to HCV recurrence after liver transplantation: Results from the AISF RECOLT-C study group
    De Martin, E.
    Senzolo, M.
    Ponziani, F. R.
    Di Paolo, D.
    Vigano, R.
    Marino, M.
    Donato, M. F.
    Rendina, M.
    Morelli, M. C.
    Fornasiero, E.
    Miglioresi, L.
    Giannelli, V.
    Fagiuoli, S.
    Burra, P.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S90 - S91
  • [36] Impact of Antiviral Therapy on Fibrosis Progression Due to HCV Recurrence after Liver Transplantation: Results from the AISF RECOLT-C Study Group
    De Martin, Eleonora
    Senzolo, Marco
    Ponziani, Francesca R.
    Vigano, Raffaella
    Iemmolo, Rosa M.
    Donato, Maria F.
    Rendina, Maria
    Morelli, Maria C.
    Fornasiero, Ezio
    Di Paolo, Daniele
    Miglioresi, Lucia
    Merli, Manuela
    Fagiuoli, Stefano
    Burra, Patrizia
    LIVER TRANSPLANTATION, 2011, 17 (06) : S97 - S97
  • [37] Hepatitis C (HCV)-3 study: Does immunosuppression (IS) affect the progression of fibrosis of HCV recurrence after liver transplantation (OLT)?
    Klintmalm, Goran B.
    Fasola, Carlos G.
    Jennings, Linda
    Heffron, Thomas G.
    Sher, Linda S.
    Mulligan, David C.
    Brown, Robert S.
    Ham, John
    Teperman, Lewis
    Rudich, Stephen
    Eckhoff, Devin E.
    Washburn, Kenneth
    Millis, Michael
    Roberts, John P.
    Charlton, Michael R.
    Baliga, Prabhakar
    Pruett, Timothy L.
    Pomfret, Elizabeth
    Koneru, Baburao
    Abecaiss, Michael M.
    HEPATOLOGY, 2007, 46 (04) : 236A - 236A
  • [38] HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION
    Lenci, I.
    Cucchiarelli, S.
    Di Maio, V. C.
    Cento, V.
    De Luca, F.
    Milana, M.
    Antonucci, F. P.
    Di Paolo, D.
    Giardina, E.
    Tisone, G.
    Angelico, M.
    Perno, C. F.
    Ceccherini-Silberstein, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S74 - S74
  • [39] SVR TO ANTIVIRAL THERAPY IS HIGHLY PROTECTIVE AGAINST LIVER-RELATED DEATH IN PATIENTS WITH HCV RECURRENCE ON THE GRAFT AFTER LIVER TRANSPLANTATION (LT)
    Rendina, Maria
    Castellaneta, Nicola Maurizio
    Fagiuoli, Stefano
    Burra, Patrizia
    Vigano, Raffaella
    Iemmolo, Rosa Maria
    Donato, Maria F.
    Toniutto, Pierluigi
    Pasulo, Luisa
    Morelli, Maria Cristina
    Miglioresi, Lucia
    Merli, Manuela
    Angelico, Mario
    Gasbarrini, Antonio
    Di Leo, Alfredo
    HEPATOLOGY, 2010, 52 (04) : 321A - 322A
  • [40] A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION
    Logge, Christoph
    Vettorazzi, Eik
    Fischer, Lutz
    Nashan, Bjoern
    Sterneck, Martina
    HEPATOLOGY, 2009, 50 (04) : 553A - 553A
12345